Segawa J, Kazuno K, Matsuoka M, Shirahase I, Ozaki M, Matsuda M, Tomii Y, Kitano M, Kise M
Chemistry Laboratories, Nippon Shinyaku Company, Ltd., Kyoto, Japan.
Chem Pharm Bull (Tokyo). 1995 Jan;43(1):63-70. doi: 10.1248/cpb.43.63.
A series of 1,8-disubstituted 6-fluoro-4-oxo-7-piperazinyl-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acid derivatives was prepared and evaluated for antibacterial activity. In the 7-piperazinyl series, addition of a fluorine at C-8, which increased the in vitro activity for the 1-hydrogen and 1-methyl analogues and decreased it for the 1-phenyl analogue, improved the in vivo activity of all the analogues. Introduction of a methoxy group at C-8 of the 1-methyl-7-piperazinyl analogue also improved its in vivo antibacterial activity. The effect of 8-substituents on the in vitro and in vivo antibacterial activity of the 1-methyl-7-(4-methyl-1-piperazinyl) series is also discussed.
制备了一系列1,8 - 二取代的6 - 氟 - 4 - 氧代 - 7 - 哌嗪基 - 4H - [1,3]噻唑并[3,2 - a]喹啉 - 3 - 羧酸衍生物,并对其抗菌活性进行了评估。在7 - 哌嗪基系列中,在C - 8位引入氟,提高了1 - 氢和1 - 甲基类似物的体外活性,降低了1 - 苯基类似物的体外活性,同时提高了所有类似物的体内活性。在1 - 甲基 - 7 - 哌嗪基类似物的C - 8位引入甲氧基也提高了其体内抗菌活性。还讨论了8 - 取代基对1 - 甲基 - 7 - (4 - 甲基 - 1 - 哌嗪基)系列体外和体内抗菌活性的影响。